drugset / Trial / NCT00962481

Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia

NCT00962481 ↗

Phase 2 Completed 18 enrolled Revotar Biopharmaceuticals AG
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety, tolerability and efficacy of repeated inhalative doses of Bimosiamose on ozone induced sputum neutrophilia in healthy subjects.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bimosiamose Small molecule — Inhaled